What are the key findings of this study?

April 21, 2015Muscle & NerveOpen Access

Toward an objective measure of functional disability in dysferlinopathy

View Full Paper

Ask AI

Bookmark

Key result

The provided text is a bibliographic citation guide from the University of Chile and does not contain clinical trial data.

Structured PICO

Population

31 patients with genetically confirmed dysferlinopathy from the Chilean population

Intervention

Clinical and functional assessment using validated scales (motor function measure [MFM], Modified Rankin Scale [MRS], Muscle Research Council [MRC] scale, serum creatine kinase [CK], spirometry, echocardiography, and electrophysiology)

Outcome

Correlation of MFM and MRC scores with disease duration, MRS, onset age, clinical phenotype, and CK levelssurrogate

The motor function measure (MFM) is a reliable outcome measure that may be useful for longitudinal follow-up in patients with dysferlinopathy.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

MFM reliability supports longitudinal monitoring in dysferlinopathy; leaves open prospective validation before routine clinical adoption.

Cite This Study

Woudt et al. (2015) studied this question. The provided text is a bibliographic citation guide from the University of Chile and does not contain clinical trial data.

synapsesocial.com/papers/6a9a1b68352e687f024d4052 https://doi.org/10.1002/mus.24685

View Full Paper

Ask AI

Bookmark

Toward an objective measure of functional disability in dysferlinopathy

Structured PICO

Discussion

Implication

Cite This Study

Toward an objective measure of functional disability in dysferlinopathy

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider